Even large molecules such as peptides, antibodies, and various types of engineered proteins can now be delivered via the lungs, Chin observes. These molecules present considerable challenges for ...

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has successfully dosed the ...

HANGZHOU, China, March 17, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation ...

Hovione today announced the launch of its Rapid Proof of Concept Study for the development of dry powder inhalation (DPI) products. Building on Hovione´s well established DPI development capability, ...

LOS ANGELES--(BUSINESS WIRE)--OTITOPIC™ recently announced a new additional indication for treatment of lung cancer for its aspirin inhalation product. Delivering an inhaled Dry Powder formulation of ...

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

AUSTIN, Texas, April 23, 2025 /PRNewswire/ -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet ...

NanoViricides Inc (NYSE:NNVC) has developed oral gummies formulations of its Pan-Coronavirus COVID-19 Drug Candidate NV-CoV-2 to benefit non-hospitalized patients. What Happened: NanoViricides ...

Bend Research Inc., part of Capsugel’s Dosage Form Solutions business unit, has made addition of Capsugel’s Xcelodose precision powder-filling technology to its drug development process. This patented ...